Cargando…
CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells
BACKGROUND: A blockade of CD44 is considered a therapeutic option for the elimination of leukemia initiating cells. However, anti-panCD44 can interfere with hematopoiesis. Therefore we explored, whether a CD44 variant isoform (CD44v)-specific antibody can inhibit leukemia growth without attacking he...
Autores principales: | Erb, Ulrike, Megaptche, Amelie Pajip, Gu, Xiaoyu, Büchler, Markus W, Zöller, Margot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022365/ https://www.ncbi.nlm.nih.gov/pubmed/24684724 http://dx.doi.org/10.1186/1756-8722-7-29 |
Ejemplares similares
-
CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells
por: Zöller, Margot
Publicado: (2015) -
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018) -
Distinct effects of two CD44 isoforms on tumor growth in vivo
Publicado: (1991) -
Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7)
por: Wittig, Bianca M., et al.
Publicado: (2000) -
CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)